If I am ill and unable to swallow my apixaban (Eliquis) tablets, is it safe to miss doses for a few days?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 3, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

No, it is not safe to skip apixaban doses for a few days if you are ill and unable to swallow tablets

If you cannot swallow apixaban tablets due to illness, you have several safe alternatives that allow you to continue taking your medication without interruption—skipping doses significantly increases your risk of stroke or blood clots.

Why Missing Doses Is Dangerous

The FDA label explicitly warns that stopping apixaban increases your risk of having a stroke, particularly in patients with atrial fibrillation 1. Apixaban has a half-life of approximately 12 hours 2, meaning the drug clears from your system relatively quickly. Missing even 2-3 days of doses can leave you without adequate anticoagulation protection, exposing you to potentially life-threatening thromboembolic events.

Safe Alternatives When You Cannot Swallow Tablets

The FDA-approved label and clinical research provide multiple validated methods to take apixaban when swallowing whole tablets is not possible:

Option 1: Crush and Mix with Water or Juice

  • Crush the tablet and suspend it in water, 5% dextrose in water (D5W), or apple juice
  • Take immediately after mixing
  • Bioavailability is comparable to whole tablets (95-105% relative bioavailability) 1, 3, 4

Option 2: Crush and Mix with Applesauce

  • Crush the tablet and mix with approximately 30 grams of applesauce
  • Take immediately
  • While this reduces exposure by approximately 16-21%, this reduction is not considered clinically significant 4

Option 3: Nasogastric Tube Administration

  • If you have a feeding tube, tablets can be crushed and suspended in 60 mL of water or D5W
  • Administer promptly through the nasogastric tube
  • Bioavailability remains adequate (95-96%) 1, 3

Critical Considerations

Avoid mixing with nutritional supplements: If using a feeding tube, do not flush with nutritional supplements, as this reduces apixaban exposure by approximately 19% and falls outside bioequivalence criteria 3. Use D5W or infant formula for flushing instead.

Food is not required: Apixaban can be taken with or without food, so you don't need to worry about eating if you're feeling too ill 1, 5.

Contact your doctor immediately: While these alternative administration methods are FDA-approved and safe, you should still inform your healthcare provider that you're having difficulty taking your medication. They need to know about your illness, especially if it involves vomiting, diarrhea, or other conditions that might affect drug absorption.

What If You've Already Missed Doses?

If you've already missed 1-2 doses, take your next scheduled dose as soon as you remember on the same day—do not double up to make up for missed doses 1. However, understand that missing multiple consecutive doses has already increased your thrombotic risk. Contact your healthcare provider urgently to discuss whether any additional monitoring or bridging therapy might be needed, particularly if you have high-risk features (CHADS₂ score ≥3, recent stroke, mechanical heart valve) 6.

The bottom line: Never simply skip apixaban doses. Use one of the FDA-approved alternative administration methods to maintain your anticoagulation and protect yourself from stroke and blood clots.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.